🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Designed to deliver personalized care, the I-SPY 2.2 trial evaluates investigational drugs to find a better outcome for each person with fewer side effects, with the goal of reducing the risk of cancer coming back. Explore more about this trial at quantumleaphealth.org/for-patients/i….

Check out the #BreastCancer Research Digest - a summary of last week’s publications from select high-impact journals (April 21st-27th, 2025). #ClinicalResearch #CancerTreatment #BCSM #BreastCancerResearch

“We are honored to welcome Dr. Woodcock, Ms. Daley, and Mr. Loiacono to our Board,” said James Palazzolo, QLHC CEO

We’re excited to announce that we are hosting another Q&A session with our Clinical Trial Navigator on Friday, May 9th.  The event will take place over Zoom, and you can RSVP in advance here: quantumleaphealth-org.zoom.us/webinar/regist…

Standard breast cancer treatment often involves aggressive chemotherapy and invasive procedures. The I-SPY 2.2 trial is changing that by focusing on personalized medicine—treating patients with the right drug at the right time based on each tumor’s unique biology.

Last Sunday, we hosted our Mothers, Daughters & Women Making Waves event in Laguna Beach. This event was a celebration of women and also a fundraiser to support breast cancer clinical trials, research, and treatment. Thank you! Together, we're making waves that matter.

This Mental Health Awareness Month, we recognize the importance of supporting both the mind and body as breast cancer can take a significant toll on mental well-being.  Many breast cancer clinical trials have a specific focus on mental health.  Visit BreastCancerTrials.org